Anbio Biotechnology
NNNN · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $1.3B · 27 employees
Latest Stock Quote
NNNN 2026-06-01
$30.17
O:$34.65 H:$34.65 L:$29.9 Vol:0.0M VWAP:$31.9394
origin leaf: 3b03649916c44ef1267621efd50317140ee6d4387c38c567bd9fe5f979c5b0b9
6 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001982708 |
| Ticker | NNNN |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | E9 |
| Website | https://www.anbio.com |
| Listed | 2025-02-19 |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 8813d5474fccee10f6227a6d391d547d6fc2da3b96075c231ab0cbec4b7afc05
parent: fa6a5a061fa7f66e5de0aa78a3b35e9b205d694977db8d9c346081c0ff637964
content hash: 451653d0267c4f82b864b906988f935e3075622ba7d24a5a855c26d8adbcd49b
signed: 2026-06-02T19:02:03.898Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf